About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Japan Animal Referral Medical Center Co.,Ltd.(6039) Financial Results

6039
TSE Growth
Japan Animal Referral Medical Center Co.,Ltd.
2,355
JPY
+43
(+1.86%)
Dec 23, 3:30 pm JST
15.03
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2021 2,847 405 410 285 120.7 0 May 6, 2021 J-GAAP
Mar, 2022 2,979 439 438 286 121.0 0 May 12, 2022 J-GAAP
Mar, 2023 3,872 580 534 380 156.3 0 May 11, 2023 J-GAAP
Mar, 2024 4,270 496 489 337 123.0 20 May 9, 2024 J-GAAP
Mar, 2025 Guidance 4,820 625 625 440 170.2 25 May 9, 2024 J-GAAP
YoY +12.9% +26.0% +27.8% +30.6% +38.4%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 4,270 580 534 380 4,168.0
Fiscal Year Mar, 2024 Mar, 2023 Mar, 2023 Mar, 2023 Mar, 2014
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 1,542 257 252 159 67.2 0 May 12, 2022 J-GAAP
Oct - Mar, 2022 1,957 287 239 183 75.3 0 May 11, 2023 J-GAAP
Oct - Mar, 2023 2,288 337 337 240 87.6 20 May 9, 2024 J-GAAP
Oct - Mar, 2024 Guidance 2,251 275 274 198 76.6 25 Nov 7, 2024 J-GAAP
YoY -1.6% -18.4% -18.7% -17.5% -12.6%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2022 439 -868 557 -1,425 722 968 13.62 J-GAAP
Mar, 2023 580 26 810 -784 820 1,816 21.17 J-GAAP
Mar, 2024 496 -86 899 -985 -392 1,337 15.25 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 1,915 293 295 197 85.0 55.2 Nov 4, 2022 J-GAAP
Apr - Sep, 2023 1,982 159 152 97 35.6 31.1 Nov 9, 2023 J-GAAP
Apr - Sep, 2024 2,569 350 351 242 93.5 56.2 Nov 7, 2024 J-GAAP
YoY +29.6% +120.1% +130.9% +149.5% +162.7%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 1,000 163 126 82 35.2 16.3 Feb 9, 2023 J-GAAP
Jan - Mar, 2023 957 124 113 101 41.6 13.0 May 11, 2023 J-GAAP
Apr - Jun, 2023 951 37 33 18 6.6 3.9 Aug 3, 2023 J-GAAP
Jul - Sep, 2023 1,031 122 119 79 29.0 11.8 Nov 9, 2023 J-GAAP
Oct - Dec, 2023 1,133 186 183 123 44.8 16.4 Feb 8, 2024 J-GAAP
Jan - Mar, 2024 1,155 151 154 117 42.7 13.1 May 9, 2024 J-GAAP
Apr - Jun, 2024 1,250 149 150 103 39.4 11.9 Aug 1, 2024 J-GAAP
Jul - Sep, 2024 1,319 201 201 139 53.7 15.2 Nov 7, 2024 J-GAAP
YoY +27.9% +64.8% +68.9% +75.9% +85.3%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 1,319 201 201 139 53.7
Fiscal Year Sep, 2024 Sep, 2024 Sep, 2024 Sep, 2024 Sep, 2024
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2022 1,078.80 35.3 7,107 2,509 1,994 1.56 May 12, 2022 J-GAAP
Mar, 2023 1,354.99 43.2 8,578 3,706 2,375 1.07 May 11, 2023 J-GAAP
Mar, 2024 1,446.52 43.5 8,770 3,811 2,712 1.01 May 9, 2024 J-GAAP
Apr - Sep, 2024 45.2 8,561 3,870 2,901 0.99 Nov 7, 2024 J-GAAP